Results 181 to 190 of about 4,891,805 (263)

Data mining revealed no other trinucleotide repeat expansion associated with the Huntington's disease biomarker (CAG). [PDF]

Clin Park Relat Disord
Alaqeeli O.
europepmc   +1 more source

Opportunistic Feeding and Parasite Assemblages in Sei Whales (Balaenoptera borealis) From Southern Chile Revealed by DNA Metabarcoding

Ecology and Evolution, Volume 16, Issue 10, October 2026.
This study represents the first metabarcoding‐based description of prey composition and parasite‐associated taxa in stranded sei whales from southern South America. ABSTRACT Balaenopterid whales are major consumers in pelagic ecosystems and play a fundamental role in marine food webs.
Daniela Haro, Guillaume Schwob, Luis Bedriñana‐Romano, Valentina Bernal‐Durán, Benjamín Cáceres, Rodrigo Hucke‐Gaete, Miguel Cáceres, Olivia Blank, Camila Calderón‐Quirgas, Mauricio Ulloa, Francisco Viddi   +10 more
wiley   +1 more source

In Vivo Mapping of Catecholaminergic Loss and Iron Deposition in Huntington's Disease. [PDF]

Mov Disord
de Natale ER, Wilson H, Karavasilis E, Liozidou A, Kartanou C, Velonakis G, Kuhle J, Zalonis I, Karadima G, Stefanis L, Koutsis G, Politis M.   +11 more
europepmc   +1 more source

Enzyme‐Digested Edible Bird's Nest Promotes NGF‐Induced Differentiation of PC12 Cells by Activating the TrkA‐ERK1/2‐CREB‐BDNF Signaling Pathway

Food Science &Nutrition, Volume 14, Issue 10, October 2026.
EBND alone upregulates neurofilament expression but does not induce neurite outgrowth in PC12 cells. With suboptimal NGF, EBND synergistically promotes neuronal differentiation via the TrkA‐ERK1/2‐CREB‐BDNF pathway. This effect is blocked by the TrkA inhibitor GW441756, confirming a TrkA‐dependent mechanism.
Wen Zhang, Xintong Wang, Huiqing Zhu, Xiaoxian Lin, Rongzi Li, Man Yuan, Baocai Xu, Dongliang Wang, Wei Xiong, Yixuan Li   +9 more
wiley   +1 more source

Correction: From Balance to Breakdown: striatal PV interneurons in Huntington's disease and Autism Spectrum Disorder. [PDF]

Front Cell Neurosci
Thabault M, Galvan L.
europepmc   +1 more source

Planning a Clinical Practice Guideline Revision for a Core Set of Outcome Measures in Adults Undergoing Neurologic Physical Therapy, Part 1: Assessing Dissemination and Scholarly Uptake

Clinical and Public Health Guidelines, Volume 3, Issue 4, October 2026.
ABSTRACT Introduction Clinical Practice Guidelines (CPGs) facilitate evidence‐based decision‐making and standardising care, yet their dissemination and scholarly uptake vary widely. The Core Set of Outcome Measures for Adults With Neurologic Conditions Undergoing Rehabilitation CPG (Core Set) has been broadly referenced within neurologic physical ...
Jennifer L. Moore, Jane E. Sullivan, Marghuretta Bland, Wendy Romney, Elizabeth Anderl, Zeynep Gulen Erkoc, Kirsten Potter   +6 more
wiley   +1 more source

Inhibition of the NLRP3 Inflammasome With MCC950 Improves Gut Health in Huntington's Disease Mice. [PDF]

J Neurochem
Sarkar SK, Ekwudo MN, Lu D, Masson B, Kiridena P, van de Garde N, Renoir T, Vince JE, Deepagan VG, Hannan AJ, Gubert C.   +10 more
europepmc   +1 more source

Frozen in Place: Proximity Labeling Maps Glial Interactomes Across Cell States

Glia, Volume 74, Issue 10, October 2026.
Proximity labeling enables cell‐type‐specific and spatially resolved mapping of glial protein networks. Proximity labeling approaches provide insights into glial function under physiological and pathological conditions. ABSTRACT Glial cells, including radial glia, oligodendrocyte precursor cells (OPCs), oligodendrocytes, astrocytes, and microglia, are ...
João Baltar, Rebecca Abati, Luísa Florido, Matthew G. Holt   +3 more
wiley   +1 more source

Exploring huntington's disease from a neurodevelopmental perspective. [PDF]

Int J Biol Sci
Huang C, Zheng X, Li W, Zhang Z, Li S, Li XJ, Rong M, Yan S.   +7 more
europepmc   +1 more source

Chemotherapy‐Induced Skeletal Muscle Dysfunction and Cognitive Impairment: A Muscle‐Brain Mechanistic Framework With Implications for Exercise Oncology

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 5, October 2026.
ABSTRACT Chemotherapy commonly induces skeletal muscle dysfunction and cognitive impairment, complications that reduce treatment tolerance and quality of life. Skeletal muscle mass frequently declines during chemotherapy, with cohort studies reporting losses of 3%–10% across treatment courses, while chemotherapy‐induced cognitive impairment affects up ...
SoYoung Ahn, Jin‐Soo Kim, Daniel A. Galvao, Dennis R. Taaffe, Dong Hyun Yoon, Carolyn McIntyre, Christelle Schofield, Yoon Jung Chang, Jihee Min, Wook Song, Robert U. Newton   +10 more
wiley   +1 more source